Clinical Trials Directory

Trials / Completed

CompletedNCT02717637

Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia

Gastrointestinal Uptake of Oxycodone After Caesarean Section in Spinal Anesthesia

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University Hospital, Akershus · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

All patients undergoing an elective caesarean section under spinal anesthesia will, according to the hospital routines, receive 10 mg oxycodone slow-release tablet when arriving at our postoperative care unit (PACU). Blood samples will be taken at 0 hour, 1 hour, 2 and 6 hours after administration in order to investigate bioavailability.

Detailed description

After written informed consent, blood samples will be taken before administration, after 1 hour, 2 hours and 6 hours. Need of rescue analgesia (morphine iv) and level of pain, as well as side effects will be registered

Conditions

Timeline

Start date
2016-02-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-03-24
Last updated
2018-01-12

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02717637. Inclusion in this directory is not an endorsement.

Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia (NCT02717637) · Clinical Trials Directory